JENNIFER RUSSELL: Open Payments
NPI 1477918902 · LEWISTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 28 payments from 15 companies in 2025. Trend: 2023 $450 · 2024 $601 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $152 |
| CVRx, Inc. | 2 | $74 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $51 |
| PFIZER INC. | 2 | $39 |
| Amgen Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: LEQVIO, Barostim Neo System, ELIQUIS, LifeVest, REPATHA, CAMZYOS, WATCHMAN FLX, VYNDAQEL.
Industry payments across NY — which companies pay providers there.
